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ABSTRAK 
Pada Penelitian di 3 desa, Tamadue, Maholo dan Winowanga di Lembah Napu, Sulawesi Ten~ah, didapatkan pre- 
valensi ovalositosis pada penduduk masinpmasing sebesar 26%, 25% dan 14%. Dari jumlah penduduk 371 yang diperik- 
sa darahnya dari ketiga desa tersebut 22% menderita ovalositosis dengan 7% di antaranya menderita malaria. Sedang- 
kan dari sisanya 78% penduduk yang mempunyai sel darah merah normal, 20Ch di antaranya menderita malaria. Per- 
bedaan ini temyata bermakna, sehingga ada korelasi antara ovalositosis dengan infeksi malaria. Ada kecenderungan 
golongan anak umur 2-9 tahun yang mempunyai ovalositosis dalam darahnya akan lebih resisten terhadap infeksi mala- 
ria dibanding golongan umur yang lain. Selain P. fakiparum, juga P. viva* dan P. malariae lebih banyak dijumpai pa& 
penderita yang mempunyai sel darah merah normal daripada penderita yang mempunyai sel darah oval. 
INTRODUCTION 
Ovalocytosis has a wide distribution 
in the Indonesian archipelago (Sofro, 
1986)l. The frequency of ovalocytosis 
ranged from 0.25% in the Javanese to 
23.7% in the Rotinese examined in his 
study. Bonne and Sandground (1939)2 
reported that half of the population in 
several villages near Lake Lindu in Cen- 
tral Sulawesi had ovalocytosis. Based 
on data collected from the Temuan of 
Malaysia, Baer et al. (1976)s hypothesi- 
zed that individuals with ovalocytosis 
are resistant to infection with malaria. 
Serjeantson et al. (197714 showed that 
in Papua New Guinea ovalocytosis is 
associated with resistance to severe mala- 
ria infections. Furthermore, individuals 
with ovalocytosis were more resistant 
to Plasmodium vivax and P. malariae 
infections, but not to  P. falciparum. 
In vitro studies show that ovalocytes 
are resistant to invasion by P. falciparum 
(Kidson et al., 1981; Hadley et al., 
1983)5,6 and P. knowlesi (Hadley et al., 
1983)~ .  We examined the frequency 
of ovdocytosis in three villages located 
approximately 50 km southeast of Lake 
Lindu in Napu Valley, Central Sulawesi 
and the relationship of ovalocytosis to 
malaria prevalence in this population. 
MATERIALS AND METHODS 
The study villages, Maholo, Wino- 
wanga and Tamadue, are located in Cen- 
tral Sulawesi, Indonesia at lo 27' south 
and 12O026' east, at an altitude of 1100 
meters above sea level. A more detailed 
description of the area was reported 
by Carney et al. (197417. Thick and 
thin blood smears from 117 residents 
of Winowanga, 154 residents of Maholo 
and 100 residents of Tamadue were pre- 
pared in March 1987 at the start of the 
dry season. Slides were stained with Giem- 
sa and examined for malaria parasites 
and ovalocytic red blood cells. 
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RESULTS with P. falciparum were the most com- 
mon. 
The prevalence of malaria by village The frequencies of ovalocytosis with 
and age group is shown in Table 1. The malaria and normal red blood cells with 
Tabel 1. Prevalence of malaria in individuals with ovalocytosis and in individuals with 
normal red blood cells by age group and village. 
Percent* with. TOTAL 
Total $ P.f.+ P.v. P.m. 
(years) Village* * examined oL,++ norm ov norm ov norm 
All ages T, M, W. 371 1 ( 5 )  11 (40)O 5 (18)0.3(1)0.3(1)17 (65) 
* Percent of individuals screened were slide positive for each malaria species, with the nunlber of positive individuals 
in parentheses. 
** T = Tamadne, M = Maholo, W = Winawanga 
+ Pf : Plawnodium falciparum, Pv : P. Vivax, Mm : P.  malaria 
++ Ov = Ovaloceptosis, norm : normal red blood cells. 
highest prevalence of malaria was found malaria in residents of the three villages 
in the two-to nine-year-olds. Infections are shown in Table 2. 
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Table 2. Frequemy of ovalocytosis and malaria in individuals with ovalocytosis and in indi 
viduals with normal red blood cells by age group and village. 
Percent * with 
Age group Total # 
(years) Examined Ovalocytosis Normal RBCS 
~ ~ ~ l o c ~ t o s i s  and malaria Normal RBcS and malaria 
25 (1) 
86  (6) 
100 ( I )  
,411 ages T, M, W 371 22 (81) 7 (16) 78 (290) 20 (59) 
* Percent of individuals screened who had ovalocytosis, ovalocytosis with malaria, and nor- 
mal red cells with malaria. Number of individuals is in parentheses. 
**  T = Tamadue, M = Maholo, W = Winowanga. 
Ovalocytosis was found in 26% of the 
residents of Tamadue, 25% of Maholo 
residents and 14% of Winowanga residents 
screened. Overall, 22% of the population 
screened had ovalocytosis and 7% with 
ovalocytosis had malaria. In comparison, 
20% of the individuals with normal red 
blood cells had malaria. The overal para- 
site rate in ovalocytics was significantly 
lower than in individuals with normal 
red blood cells (x2 = 6.18; p = 0.013). 
However, when the data is examined 
by age group the advantage of ovalocy- 
tosis was seen only in the 2 to  9 year 
olds, not in the other age groups. All 
persons with malaria and ovalocytosis 
had P. falciparum infections except for 
one child below the age of two who had 
P. rnalariae. 
DISCUSSION 
An advantage conferred by ovalocy- 
tosis to  residents of a malarious area in 
Napu Valley, Central Sulawesi was seen 
in two-to nine-year olds who were resis- 
tant to  infection with malaria. Only one 
of the two to  nine year olds with ovalo- 
cytosis had malaria, while 16% to  57% 
of those with normal red blood cells 
had malaria '(P. falciparum, P. vivax o r  
P. malariae) at  the time of screening. 
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In all age groups, P. falciparum was the 
only malaria species found in ovalocy- 
tics, except one child below the age of 
two who had an infection of P. malariae. 
This is in agreement with the results of 
Serjeantson et al. (1977) who found 
that there was a significantly reduced 
rote of P. v i ~ m  and P. malariae in ova- 
locytics. However, in contrast to this 
results we observed an age-specific resis- 
tance of individuals with ovalocytosis 
to infection with all species malaria. Since 
the sample size in this study was small, 
additional malaria surveys of this popu- 
la%ion should .be done at different times 
of the year to confirm that individuals 
with ovalocytosis are resistant to infec- 
tion with malaria and that the advantage 
is age-specific. 
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